Remimazolam, a novel drug, for safe and effective endoscopic sedation
Open Access
- 30 May 2025
- journal article
- research article
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (3) , 370-376
Abstract
Remimazolam is a novel benzodiazepine with unique pharmacokinetic and pharmacodynamic properties, making it an ideal candidate for sedation during endoscopic procedures. Distinguished by its rapid onset and short duration of action, remimazolam offers a safer and more efficient alternative to traditional sedatives, such as midazolam and propofol, with fewer side effects, such as hypotension, bradycardia, and respiratory depression. This article reviews the characteristics of remimazolam and its practical advantages, including ease of use, quick recovery time, and minimal residual sedation, emphasizing its potential to improve patient safety and procedural efficiency in clinical endoscopy settings.Keywords
This publication has 35 references indexed in Scilit:
- Remimazolam versus propofol for sedation in gastrointestinal endoscopy and colonoscopy within elderly patients: a meta-analysis of randomized controlled trialsEuropean Journal of Clinical Pharmacology, 2024
- Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairmentBritish Journal of Anaesthesia, 2021
- Re-sleeping after reversal of remimazolam by flumazenilJournal of Anesthesia, 2021
- Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trialDigestive and Liver Disease, 2021
- Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trialJournal of Anesthesia, 2020
- A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopyGastrointestinal Endoscopy, 2018
- Guidelines for sedation and anesthesia in GI endoscopyGastrointestinal Endoscopy, 2018
- The Role of GABA Receptor Agonists in Anesthesia and SedationCNS Drugs, 2017
- Remimazolam: Pharmacologic Considerations and Clinical Role in AnesthesiologyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopyGastrointestinal Endoscopy, 2016